paper-with-me

Papers

MADD: Multi-Agent Drug Discovery Orchestra

2025-11-11 · Gleb V. Solovev, Alina B. Zhidkovskaya, Anastasia Orlova, Nina Gubina, Anastasia Vepreva, Rodion Golovinskii, Ilya Tonkii, Ivan Dubrovsky, Ivan Gurev, Dmitry Gilemkhanov, Denis Chistiakov, Timur A. Aliev, Ivan Poddiakov, Galina Zubkova, Ekaterina V. Skorb, Vladimir Vinogradov, Alexander Boukhanovsky, Nikolay Nikitin, Andrei Dmitrenko, Anna Kalyuzhnaya, Andrey Savchenko arxiv

Hit identification is a central challenge in early drug discovery, traditionally requiring substantial experimental resources. Recent advances in artificial intelligence, particularly large language models (LLMs), have enabled virtual screening methods that reduce costs and improve efficiency. However, the growing complexity of these tools has limited their accessibility to wet-lab researchers. Multi-agent systems offer a promising solution by combining the interpretability of LLMs with the precision of specialized models and tools. In this work, we present MADD, a multi-agent system that builds and executes customized hit identification pipelines from natural language queries. MADD employs four coordinated agents to handle key subtasks in de novo compound generation and screening. We evaluate MADD across seven drug discovery cases and demonstrate its superior performance compared to existing LLM-based solutions. Using MADD, we pioneer the application of AI-first drug design to five biological targets and release the identified hit molecules. Finally, we introduce a new benchmark of query-molecule pairs and docking scores for over three million compounds to contribute to the agentic future of drug design.

📄 PDF Abstract BibTeX arXiv:2511.08217

Code (0)

등록된 구현이 없습니다.

Tasks

Natural Language QueriesDrug Discovery

Similar Papers 제목 키워드 기반

Democratizing Drug Discovery with an Orchestrated, Knowledge-Driven Multi-Agent Team for User-Guided Therapeutic Design

2025-12-25 · Takahide Suzuki, Kazuki Nakanishi, Takashi Fujiwara, Hideyuki Shimizu arxiv

Therapeutic discovery remains a formidable challenge, impeded by the fragmentation of specialized domains and the execution gap between computational design and physiological validation. Although generative AI offers pro…

Drug Discovery

FROGENT: An End-to-End Full-process Drug Design Multi-Agent System

2025-08-14 · Qihua Pan, Dong Xu, Qianwei Yang, Jenna Xinyi Yao 외 arxiv

Drug discovery is a complex, multi-step pipeline that remains heavily dependent on manual, experience-driven operations; meanwhile, existing customized artificial intelligence tools are fragmented across web applications…

Drug Discovery

MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization

2026-04-02 · Lisheng Zhang, Lilong Wang, Xiangyu Sun, Wei Tang 외 arxiv

Computational drug discovery, particularly the complex workflows of drug molecule screening and optimization, requires orchestrating dozens of specialized tools in multi-step workflows, yet current AI agents struggle to …

Drug Discovery

Exploring Modularity of Agentic Systems for Drug Discovery

2025-06-27 · Laura van Weesep, Samuel Genheden, Ola Engkvist, Jens Sjölund

Large-language models (LLMs) and agentic systems present exciting opportunities to accelerate drug discovery and design. In this study, we critically examine the modularity of LLM-based agentic systems for drug discovery…

Drug Discovery

Technical Implementation of Tippy: Multi-Agent Architecture and System Design for Drug Discovery Laboratory Automation

2025-07-18 · Yao Fehlis, Charles Crain, Aidan Jensen, Michael Watson 외 arxiv

Building on the conceptual framework presented in our previous work on agentic AI for pharmaceutical research, this paper provides a comprehensive technical analysis of Tippy's multi-agent system implementation for drug …

Drug Discovery